Document is current
Any future updates will be listed below
-
Authors
González-Gualda, Estela
Reinius, Marika A. V.
Macias, David https://orcid.org/0000-0002-8676-1964
Morsli, Samir https://orcid.org/0000-0002-0371-0732
Ge, Jianfeng
Olan, Ioana https://orcid.org/0000-0003-0692-1831
Martín, José Ezequiel
Ou, Hui-Ling
Hartono, Muhamad
Puerto-Camacho, María Pilar
Denholm, Mary https://orcid.org/0000-0001-5875-4487
Kieran, Rosalind
Hoffmann, Reuben
Dane, Mark
Veroutis, Dimitris
Medrano, Guillermo
Mulero, Francisca https://orcid.org/0000-0001-9584-4211
Jimenez-Linan, Mercedes
Fruk, Ljiljana
Martins, Carla P.
Barbacid, Mariano
Gorgoulis, Vassilis https://orcid.org/0000-0001-9001-4112
Korkola, James E.
Rassl, Doris M.
Doherty, Gary J. https://orcid.org/0000-0002-8158-8111
Rintoul, Robert C. https://orcid.org/0000-0003-3875-3780
Narita, Masashi https://orcid.org/0000-0001-7764-577X
Brenton, James D. https://orcid.org/0000-0002-5738-6683
Muñoz-Espín, Daniel https://orcid.org/0000-0002-0550-9514
- License Information
-
More Information
Article History
Received: 17 January 2025
Accepted: 11 December 2025
First Online: 3 February 2026
Competing interests
: E.G-G. is now an employee of Eli Lilly and Company, Spain. G.J.D. and C.P.M. are now employees of AstraZeneca, UK. J.D.B. is a cofounder and shareholder of Tailor Bio. The rest of the authors declare no competing interests.
